An Open-label Study of the Safety and Efficacy of Tag-7 Gene-modified Tumor Cell-based Vaccine in Patients With Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

An Open‐Label Study of the Safety and Efficacy of Tag‐7 Gene‐Modified Tumor Cells‐Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

The Oncologist ◽

10.1634/theoncologist.2020-0160 ◽

2020 ◽

Vol 25 (9) ◽

Author(s):

Aleksei Viktorovich Novik ◽

Anna Borisovna Danilova ◽

Maksim Ivanovich Sluzhev ◽

Tatiana Leonidovna Nehaeva ◽

Sergei Sergeevich Larin ◽

...

Keyword(s):

Malignant Melanoma ◽

Tumor Cells ◽

Renal Cell ◽

Cell Cancer ◽

Locally Advanced ◽

Metastatic Malignant Melanoma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-005-0070-z ◽

2005 ◽

Vol 57 (4) ◽

pp. 533-539 ◽

Cited By ~ 38

Author(s):

Monika Jermann ◽

Rolf A Stahel ◽

Marc Salzberg ◽

Thomas Cerny ◽

Markus Joerger ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Locally Advanced ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A phase 1b/2a, multi-center, open-label study to evaluate the safety and efficacy of combination treatment with MEDI0457 (INO-3112) and durvalumab (MEDI4736) in patients with recurrent/metastatic human papilloma virus–associated head and neck squamous cell cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps6093 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS6093-TPS6093 ◽

Cited By ~ 2

Author(s):

Charu Aggarwal ◽

Balazs Halmos ◽

Mercedes Porosnicu ◽

Nabil F. Saba ◽

Ammar Sukari ◽

...

Keyword(s):

Human Papilloma Virus ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Open Label ◽

Papilloma Virus ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Phase 1B ◽

Neck Squamous Cell Cancer

Download Full-text

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations: Erratum

Medicine ◽

10.1097/md.0000000000028585 ◽

2022 ◽

Vol 101 (2) ◽

pp. e28585

Keyword(s):

Combination Therapy ◽

Locally Advanced ◽

Egfr Mutations ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Metastatic Nsclc ◽

Nsclc Patients

Download Full-text

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

Journal of Translational Medicine ◽

10.1186/1479-5876-7-68 ◽

2009 ◽

Vol 7 (1) ◽

pp. 68 ◽

Cited By ~ 29

Author(s):

Antoni Ribas ◽

John M Kirkwood ◽

Michael B Atkins ◽

Theresa L Whiteside ◽

William Gooding ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase I ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Biologic Effects

Download Full-text

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations

Medicine ◽

10.1097/md.0000000000023455 ◽

2020 ◽

Vol 99 (49) ◽

pp. e23455

Author(s):

Si-Yeon Song ◽

Su-Jeong Ha ◽

Ji-Hye Park ◽

So-Jung Park ◽

Seong Hoon Shin ◽

...

Keyword(s):

Combination Therapy ◽

Locally Advanced ◽

Egfr Mutations ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Metastatic Nsclc ◽

Nsclc Patients

Download Full-text

Updated Os Analysis, Multivariate and Qtwist Analysis of a Randomized Sequential Open-Label Study (Switch) to Evaluate Efficacy and Safety of Sorafenib (So) / Sunitinib (Su) Versus Su/So in the Treatment of Metastatic Renal Cell Cancer (Mrcc)

Annals of Oncology ◽

10.1093/annonc/mdu337.28 ◽

2014 ◽

Vol 25 ◽

pp. iv290 ◽

Cited By ~ 1

Author(s):

C. Eichelberg ◽

P.J. Goebell ◽

W.L. Vervenne ◽

M. De Santis ◽

L. Fischer von Weikersthal ◽

...

Keyword(s):

Renal Cell Cancer ◽

Renal Cell ◽

Cell Cancer ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Metastatic Renal Cell Cancer

Download Full-text

SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer

European Urology ◽

10.1016/j.eururo.2015.04.017 ◽

2015 ◽

Vol 68 (5) ◽

pp. 837-847 ◽

Cited By ~ 82

Author(s):

Christian Eichelberg ◽

Walter L. Vervenne ◽

Maria De Santis ◽

Ludwig Fischer von Weikersthal ◽

Peter J. Goebell ◽

...

Keyword(s):

Renal Cell Cancer ◽

Renal Cell ◽

Cell Cancer ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Metastatic Renal Cell Cancer

Download Full-text

Subgroup analyses of a randomized sequential open-label study (SWITCH) to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4567 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4567-4567 ◽

Cited By ~ 4

Author(s):

Peter J. Goebell ◽

Walter Vervenne ◽

Maria De Santis ◽

Ludwig Fischer Von Weikersthal ◽

Christian A. Lerchenmuller ◽

...

Keyword(s):

Renal Cell Cancer ◽

Renal Cell ◽

Cell Cancer ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Metastatic Renal Cell Cancer ◽

Subgroup Analyses

Download Full-text

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Case Medical Research ◽

10.31525/ct1-nct03977792 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Labialis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Recurrent Herpes ◽

Cold Sores

Download Full-text